Compounds > aspartic acid
Page last updated: 2024-08-17

aspartic acid and Amentia

aspartic acid has been researched along with Amentia in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19906 (12.24)18.7374
1990's8 (16.33)18.2507
2000's22 (44.90)29.6817
2010's13 (26.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garringer, HJ; Ghetti, B; Gnezda, A; Murrell, J; Sammeta, N; Vidal, R1
Kantarci, K2
Augusciak-Duma, AM; Banasik, TJ; Bujak, MA; Opala, G; Siuda, JS; Targosz-Gajniak, MG; Wicher, MM1
Arai, H; Fujii, C; Hata, S; Higuchi, S; Igarashi, K; Ishii, R; Iwai, N; Moriya, M; Ohrui, T; Suzuki, T; Tokuda, T; Uemura, K; Waragai, M; Yoshida, M1
Dubovický, M; Kašparová, S; Kucharská, J; Liptaj, T; Lipták, B; Sumbalová, Z; Szomolányi, P; Trattnig, S; Tušková, R; Uličná, O; Vančová, O1
Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL1
Kawamata, T; Ryu, B; Shimizu, M; Shimizu, T; Wakai, T; Yagi, S1
Abner, E; Caban-Holt, A; Davis, R; Gold, BT; Head, E; Jicha, G; Lin, AL; Powell, D; Robertson, W; Schmitt, FA; Wilcock, DM1
Antúnez, C; Carles, R; Fortuna, L; García Santos, JM; Gavrila, D; Jiménez Veiga, J; Navarro, C; Parrilla, G; Salmerón, D; Tormo, MJ; Torres del Río, S1
Ahrens, RJ; Caserta, MT; Hermida, AP; Ragin, A; Wise, L1
Boeve, BF; Jack, CR; Kantarci, K; Knopman, DS; Negash, S; O'Brien, PC; Petersen, RC; Przybelski, SA; Shiung, MM; Weigand, SD; Whitwell, JL1
Frölich, L; Kratzsch, T; Lais, C; Lanfermann, H; Maurer, K; Pantel, J; Pilatus, U; Rochmont, Adu M; Zanella, FE1
Bakar, M; Gumustas, O; Parlayan, E; Yulug, B1
Essig, M; Gerigk, L; Giesel, F; Hauser, T; Schuster, L1
Archer, N; Beacher, F; Daly, E; Foy, CML; Lamar, M; Lovestone, S; Morris, RG; Murphy, DGM; Murphy, KC; Poppe, M; Prasher, V; Simmons, A1
Arlt, S; Block, W; Ende, G; Frölich, L; Gür, O; Hammen, T; Jessen, F; Kornhuber, J; Kucinski, T; Lewczuk, P; Maier, W; Peters, O; Popp, J; Träber, F; Wiltfang, J1
Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J1
Bacher, R; Kemmler, G; Lingg, A; Marksteiner, J; Vonbank, H; Weiss, U1
Ito, H; Kizu, O; Nishimura, T; Yamada, K1
Boeve, BF; Edland, SD; Ferman, TJ; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; O'Brien, PC; Petersen, RC; Smith, GE; Tang-Wai, DF; Tangalos, EG; Weigand, SD1
Ahn, KH; Cohen, BM; Frederick, BD; Kim, MJ; Lyoo, IK; Renshaw, PF; Satlin, A; Yurgelun-Todd, DA1
Capizzano, AA; Chao, LL; Chui, HC; Du, AT; Jagust, WJ; Kramer, JH; Miller, BL; O'Neill, J; Schuff, N; Weiner, MW; Wolkowitz, OM; Yaffe, K1
Adalsteinsson, E; Pfefferbaum, A; Sullivan, EV1
Cherubini, A; Feliziani, FT; Gobbi, G; Mariani, E; Mecocci, P; Metastasio, A; Pelliccioli, GP; Rinaldi, P; Senin, U; Tarducci, R1
Abe, K; Hattori, N; Mihara, M; Sakoda, S; Sawada, T1
Birchall, D; Coulthard, E; English, P; Firbank, M; Griffiths, TD; O'Brien, J; Welch, J1
Armendariz, J; Behrens, MI; Budde, J; Cairns, NJ; Chakraverty, S; Gitcho, M; Goate, AM; Hinrichs, AL; Kauwe, JS; Levitch, D; Liscic, RM; Morris, JC; Mukherjee, O; Norton, J; Pastor, P; Shears, S; Taylor-Reinwald, L; Tenenholz Grinberg, L; Tu, PH1
Fox, NC; Garrard, P; Hodges, JR; MacManus, DG; Schott, JM; Waldman, AD1
Bosch, B; Caprile, C; Gómez-Ansón, B; Molinuevo, JL; Monte, GC; Rami, L; Sánchez-Valle, R1
Ding, M; Gong, X; Xuan, X1
Bowen, DM; Davison, AN; Neary, D; Sims, NR; Smith, CC1
Blessed, G; Perry, EK; Perry, RH; Tarbit, I; Tomlinson, BE1
Constans, JM; Fein, G; Gerson, J; MacKay, S; Meyerhoff, DJ; Norman, D; Weiner, MW1
Ross, BD; Shonk, T1
Gifford, P; Izumi, J; Mandigo, JC; Michaelis, T; Moats, RA; Ross, BD; Shonk, TK1
Block, RE; Bowen, BC; Lampman, DA; Murdoch, JB; Pattany, PM; Quencer, RM; Sanchez-Ramos, J1
Bowen, DM; Francis, PT; Holmes, C; Procter, AW; Webster, MT1
Akiguchi, I; Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Shiino, A1
Chang, L; Ernst, T; Mehringer, CM; Melchor, R1
Becerra, L; Cheng, LL; González, RG; Lackner, A; Ma, MJ; Ptak, T; Tracey, I1
Eberling, JL; Ezekiel, F; Jagust, W; Klein, G; O'Neill, J; Reed, B; Schuff, N; Soto, G; Weiner, MW1
Goto, T; Inoue, T; Matsuoka, N; Moriguchi, A; Shirakawa, K; Wang, F1
Harada, M; Miyoshi, H; Nishitani, H; Otsuka, H; Uno, M1
Alexander, GE; Chang, L; Huang, W; Krasuski, JS; Rapoport, SI; Schapiro, MB; Shetty, HU1
Chang, LJ; Hornykiewicz, O; Kish, SJ; Mirchandani, L; Shannak, K1
Bowen, DM; Francis, PT; Neary, D; Smith, CC; Snowden, JS1
Connick, JH; English, M; Hastings, MH; Stone, TW; Winn, P1
Wilde, KM1

Reviews

3 review(s) available for aspartic acid and Amentia

ArticleYear
Proton MRS in mild cognitive impairment.
    Journal of magnetic resonance imaging : JMRI, 2013, Volume: 37, Issue:4

    Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Diagnosis, Differential; Disease Models, Animal; Disease Progression; Energy Metabolism; Humans; Inositol; Magnetic Resonance Spectroscopy; Mice; Translational Research, Biomedical

2013
Magnetic resonance spectroscopy in common dementias.
    Neuroimaging clinics of North America, 2013, Volume: 23, Issue:3

    Topics: Aspartic Acid; Biomarkers; Brain; Dementia; Humans; Inositol; Magnetic Resonance Spectroscopy

2013
Endogenous excitotoxic agents.
    Ciba Foundation symposium, 1987, Volume: 126

    Topics: Animals; Aspartic Acid; Cell Survival; Central Nervous System; Dementia; Epilepsy; Glutamates; Glutamic Acid; Humans; Huntington Disease; Models, Neurological; Neurons; Quinolinic Acid; Quinolinic Acids

1987

Trials

2 trial(s) available for aspartic acid and Amentia

ArticleYear
Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition Disorders; Creatine; Data Collection; Dementia; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Predictive Value of Tests; Protons; Residence Characteristics; Sensitivity and Specificity; Severity of Illness Index

2008
Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
    Radiology, 1995, Volume: 195, Issue:1

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases, Metabolic; Creatine; Dementia; Diagnosis, Differential; Double-Blind Method; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Predictive Value of Tests; Sensitivity and Specificity

1995

Other Studies

44 other study(ies) available for aspartic acid and Amentia

ArticleYear
Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Animals; Aspartic Acid; Cataract; Cerebellar Ataxia; Deafness; Dementia; Female; Gene Expression; Hippocampus; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Neocortex; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Synaptophysin; tau Proteins

2013
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Protons

2013
Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Journal of Alzheimer's disease : JAD, 2014, Volume: 41, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Brain; Choline; Dementia; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Retrospective Studies; Tritium

2014
Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study.
    Behavioural brain research, 2015, May-01, Volume: 284

    Topics: Animals; Aspartic Acid; Biomarkers; Brain; Dementia; Dipeptides; Disease Models, Animal; Galactose; Inositol; Magnetic Resonance Spectroscopy; Male; Nootropic Agents; Organ Size; Phosphorus Isotopes; Protons; Rats, Wistar; Simvastatin; Spatial Learning; Spatial Memory; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Ubiquinone

2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Parkinsonism & related disorders, 2016, Volume: 22

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus

2016
Reversible Cerebral Metabolism Changes Using Proton Magnetic Resonance Spectroscopy in a Patient with Intracranial Dural Arteriovenous Fistula: A Case Report.
    World neurosurgery, 2016, Volume: 92

    Topics: Aged; Aspartic Acid; Central Nervous System Vascular Malformations; Coronary Angiography; Creatine; Dementia; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Proton Magnetic Resonance Spectroscopy

2016
(1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.
    NeuroImage. Clinical, 2016, Volume: 11

    Topics: Activities of Daily Living; Adult; Analysis of Variance; Aspartic Acid; Dementia; Down Syndrome; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Neuropsychological Tests; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Surveys and Questionnaires

2016
Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.
    Psychiatry research, 2008, Nov-30, Volume: 164, Issue:2

    Topics: Aged; Aspartic Acid; Choline; Creatine; Dementia; Female; Functional Laterality; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Severity of Illness Index

2008
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Neurology, 2009, Apr-28, Volume: 72, Issue:17

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Atrophy; Biomarkers; Brain; Cerebrovascular Disorders; Cognition Disorders; Cohort Studies; Creatine; Dementia; Disease Progression; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Factors

2009
Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Psychiatry research, 2009, Jul-15, Volume: 173, Issue:1

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Follow-Up Studies; Glutamine; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Parietal Lobe; Prognosis; Severity of Illness Index

2009
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect.
    The Journal of neuropsychiatry and clinical neurosciences, 2009,Summer, Volume: 21, Issue:3

    Topics: Aged; Aspartic Acid; Brain; Cognition Disorders; Dementia; Donepezil; Female; Humans; Indans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome

2009
[MR spectroscopy in dementia].
    Der Radiologe, 2010, Volume: 50, Issue:9

    Topics: Aspartic Acid; Biomarkers; Brain; Creatinine; Dementia; Humans; Magnetic Resonance Spectroscopy; Oligopeptides; Phosphorylcholine; Protons

2010
Down syndrome with and without dementia: an in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease.
    NeuroImage, 2011, Jul-01, Volume: 57, Issue:1

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain Chemistry; Case-Control Studies; Dementia; Down Syndrome; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged

2011
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia.
    Journal of Alzheimer's disease : JAD, 2011, Volume: 27, Issue:2

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Dementia; Female; Humans; Male; Middle Aged; Mitochondria; Neurons; Peptide Fragments

2011
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:5-6

    Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed

2012
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Choline; Cognition Disorders; Creatine; Dementia; Dementia, Vascular; Diagnosis, Differential; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Pick Disease of the Brain; Retrospective Studies; Temporal Lobe

2003
Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy.
    Neuroradiology, 2004, Volume: 46, Issue:4

    Topics: Adult; Aged; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dementia; Diagnosis, Differential; Female; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Radiography

2004
1H MR spectroscopy in common dementias.
    Neurology, 2004, Oct-26, Volume: 63, Issue:8

    Topics: Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Dementia; Dementia, Vascular; Diagnosis, Differential; Down-Regulation; Female; Humans; Inositol; Lewy Body Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurodegenerative Diseases; Protons

2004
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:8

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain Mapping; Case-Control Studies; Choline; Cognition Disorders; Creatine; Dementia; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Mental Status Schedule; Protons; Temporal Lobe

2004
Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.
    Neurology, 2005, Jan-25, Volume: 64, Issue:2

    Topics: Aged; Aspartic Acid; Atrophy; Cognition Disorders; Dementia; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Parietal Lobe; Risk Factors; Temporal Lobe

2005
Cortical NAA deficits in HIV infection without dementia: influence of alcoholism comorbidity.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:7

    Topics: Adult; Alcoholism; Aspartic Acid; Brain Mapping; Case-Control Studies; Cerebral Cortex; Choline; Comorbidity; Creatine; Dementia; Female; HIV Infections; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged

2005
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Neurobiology of aging, 2006, Volume: 27, Issue:7

    Topics: Aged; Amnesia; Aspartic Acid; Cerebral Cortex; Choline; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Functional Laterality; Humans; Inositol; Lateral Ventricles; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Nerve Fibers, Myelinated; Predictive Value of Tests; Protons

2006
Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Neuroreport, 2006, Mar-20, Volume: 17, Issue:4

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain Mapping; Cerebral Cortex; Creatine; Dementia; Down-Regulation; Energy Metabolism; Female; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Pick Disease of the Brain

2006
Proton magnetic resonance spectroscopy in frontotemporal dementia.
    Journal of neurology, 2006, Volume: 253, Issue:7

    Topics: Aged; Aspartic Acid; Biomarkers; Cerebral Cortex; Dementia; Female; Frontal Lobe; Gliosis; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parietal Lobe; Predictive Value of Tests; Temporal Lobe

2006
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Annals of neurology, 2006, Volume: 60, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Chromosomes, Human, Pair 17; Dementia; DNA Mutational Analysis; Family Health; Female; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Inclusion Bodies; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Mutation, Missense; Neuropsychological Tests; tau Proteins; Ubiquitin; Valine

2006
Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2006, Volume: 19, Issue:4

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Atrophy; Dementia; Diagnosis, Differential; Female; Frontal Lobe; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Matched-Pair Analysis; Middle Aged; Temporal Lobe

2006
Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases.
    Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:3

    Topics: Aged; Amnesia; Anomia; Aspartic Acid; Choline; Cognition Disorders; Creatine; Dementia; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Prevalence; Severity of Illness Index; Temporal Lobe

2008
Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2008, Volume: 18, Issue:2

    Topics: Aged; Aspartic Acid; Chi-Square Distribution; Choline; Creatine; Dementia; Female; Hippocampus; Humans; Lewy Body Disease; Magnetic Resonance Spectroscopy; Male; Protons

2008
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.
    Brain research, 1983, Mar-28, Volume: 264, Issue:1

    Topics: Acetylcholine; Alzheimer Disease; Amino Acids; Aspartic Acid; Dementia; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Potassium; Temporal Lobe

1983
Hippocampal free amino acids in Alzheimer's disease.
    Journal of neurochemistry, 1980, Volume: 35, Issue:5

    Topics: Aged; Alzheimer Disease; Amino Acids; Arginine; Aspartic Acid; Dementia; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Humans; Middle Aged

1980
H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
    Radiology, 1995, Volume: 197, Issue:2

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases; Brain Ischemia; Case-Control Studies; Cerebral Ventricles; Choline; Creatine; Dementia; Dementia, Vascular; Female; Humans; Hydrogen; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurologic Examination

1995
Role of increased cerebral myo-inositol in the dementia of Down syndrome.
    Magnetic resonance in medicine, 1995, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Alzheimer Disease; Aspartic Acid; Brain; Child; Child, Preschool; Choline; Creatine; Dementia; Down Syndrome; Humans; Inositol; Magnetic Resonance Spectroscopy; Middle Aged

1995
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dementia; Energy Metabolism; Female; Humans; Lactates; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphocreatine; Protons

1995
Relationship between beta-amyloid precursor protein, pyramidal neurones and astrocytes in human neocortex.
    Biochemical Society transactions, 1993, Volume: 21 ( Pt 3), Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Antibodies, Monoclonal; Aspartic Acid; Biological Transport; Dementia; Electrophoresis, Polyacrylamide Gel; Frontal Lobe; Humans; Immunoblotting; Molecular Weight; Temporal Lobe

1993
Proton magnetic resonance spectroscopy with dementia.
    Surgical neurology, 1993, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Creatine; Dementia; Female; Humans; Hydrocephalus, Normal Pressure; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Reference Values

1993
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
    Radiology, 1997, Volume: 203, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Dementia; Discriminant Analysis; Female; Frontal Lobe; Glutamic Acid; Glutamine; Humans; Hydrogen; Inositol; Lactates; Linear Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Neuroglia; Neurons; Parietal Lobe; Protons; Sensitivity and Specificity; Temporal Lobe

1997
Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Jun-10, Volume: 94, Issue:12

    Topics: Amino Acids; Animals; Aspartic Acid; Biomarkers; Brain; Cerebral Cortex; Dementia; Haplorhini; Humans; Magnetic Resonance Spectroscopy; Neurons; Organ Specificity; Pathology; Reproducibility of Results

1997
Method to correlate 1H MRSI and 18FDG-PET.
    Magnetic resonance in medicine, 2000, Volume: 43, Issue:2

    Topics: Aged; Algorithms; Analysis of Variance; Aspartic Acid; Brain; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed

2000
FK960, a novel potential anti-dementia drug, enhances high K(+)-evoked release of somatostatin from rat hippocampal slices.
    Brain research, 2001, Feb-16, Volume: 892, Issue:1

    Topics: Acetylcholine; Animals; Aspartic Acid; Benzamides; Dementia; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Male; Nootropic Agents; Piperazines; Potassium; Rats; Rats, Inbred F344; Serotonin; Somatostatin; Stereoisomerism

2001
Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy.
    Neuroradiology, 2001, Volume: 43, Issue:6

    Topics: Adult; Aged; Aging; Aspartic Acid; Cerebrospinal Fluid; Corpus Striatum; Dementia; Female; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Reference Values

2001
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Neurology, 2001, Aug-28, Volume: 57, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain; Choline; Creatine; Dementia; Female; Humans; Hydrogen; Inositol; Magnetic Resonance Imaging; Male; Middle Aged; Regression Analysis

2001
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
    Annals of neurology, 1985, Volume: 18, Issue:5

    Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltransferase; Dementia; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Neurons; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Serotonin

1985
Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:5

    Topics: Adult; Aged; Alzheimer Disease; Amino Acids; Aspartic Acid; Dementia; Epilepsy; Female; Glutamates; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents

1985
[Comments on a geriatric drug].
    Zeitschrift fur Allgemeinmedizin, 1974, Feb-28, Volume: 50, Issue:6

    Topics: Aged; Asparagine; Aspartic Acid; Dementia; Drug Combinations; Female; Hematoporphyrins; Humans; Magnesium; Male; Orotic Acid; Potassium; Procaine

1974